Search research articles
Contact Us
Filters
Showing results (501-510 of 630) with videos related to
Page
of 63
Sort By:
Blood
|
May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Ginna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
British Journal of Haematology
|
April 12, 2017
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib
Jeffrey A Jones, Peter Hillmen, Steven Coutre, et al.
Leukemia
|
June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Leukemia & Lymphoma
|
November 18, 2022
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
John Kuruvilla, Philippe Armand, Mehdi Hamadani, et al.
Blood Advances
|
July 23, 2024
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel
Nausheen Ahmed, William Wesson, Forat Lutfi, et al.
The New England Journal of Medicine
|
December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Blood Advances
|
November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Cancer Medicine
|
May 16, 2026
Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance
Carolyn Y Fang, Alexander W MacFarlane, Henry C H Fung, et al.
Blood Advances
|
June 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis
Kitsada Wudhikarn, Maria Bromberg, Jamie Brower, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results
John P Leonard, Morton Coleman, Jamie C Ketas, et al.
Page
of 63
Search research articles
Search
Showing results (501-510 of 630) with videos related to
Sort By:
Page
of 63
Blood
|
May 24, 2003
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Ginna G Laport, Bruce L Levine, Edward A Stadtmauer, et al.
British Journal of Haematology
|
April 12, 2017
Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib
Jeffrey A Jones, Peter Hillmen, Steven Coutre, et al.
Leukemia
|
June 30, 2018
LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting
Lorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Leukemia & Lymphoma
|
November 18, 2022
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
John Kuruvilla, Philippe Armand, Mehdi Hamadani, et al.
Blood Advances
|
July 23, 2024
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel
Nausheen Ahmed, William Wesson, Forat Lutfi, et al.
The New England Journal of Medicine
|
December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Blood Advances
|
November 10, 2022
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, et al.
Cancer Medicine
|
May 16, 2026
Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance
Carolyn Y Fang, Alexander W MacFarlane, Henry C H Fung, et al.
Blood Advances
|
June 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis
Kitsada Wudhikarn, Maria Bromberg, Jamie Brower, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 2004
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results
John P Leonard, Morton Coleman, Jamie C Ketas, et al.
Page
of 63